611 MYLAN (Methyldopa 250 mg)

Pill imprint 611 MYLAN has been identified as Methyldopa 250 mg.

Methyldopa is used in the treatment of hypertensive emergency; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 611 MYLAN

Methyldopa 250 mg 611 MYLAN
Methyldopa 250 mg 611 MYLAN
Methyldopa 250 mg 611 MYLAN Front
Methyldopa 250 mg 611 MYLAN Back
Methyldopa 250 mg 611 MYLAN
Methyldopa
Imprint:
611
MYLAN
Strength:
250 mg
Color:
Beige
Size:
11.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0611
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
triacetin
FD&C Yellow No. 6
FD&C Blue No. 2
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0200 UDL Laboratories Inc
54569-0508 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)